Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 411-423

  Meyer, John S ^a,b   Rauch, Gaiane M ^a   Rauch, Ronald A ^a   Haque, Anwarul ^a   Crawford, Kate ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DENSITOMETRY; FAMILY HISTORY; FEMALE; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NORMAL HUMAN; RISK FACTOR; SEX DIFFERENCE; SMOKING; TRANSIENT ISCHEMIC ATTACK;

EID: 0034100759     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06393.x     Document Type: Conference Paper

References (41)

1. 1. KATZMAN, R. et al. 1989. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann. Neurol. 25: 317-324.
2. 2. MEYER, J.S. et al. 1994. CT changes associated with normal aging of the human brain. J. Neurol. Sci. 123: 200-208.
3. 3. MEYER, J.S. et al. 1994. Problems encountered with longitudinal neurological, psychometric and cerebral CT imaging among stroke data bank patients with dementia. Neuroepidemiology 13: 340-344.
4. 4. PERSSON, G. et al. 1996. A prospective population study of psychosocial risk factors for late onset dementia. Intern. J. Geriat. Psychiat. 11: 15-22.
5. 5. DESMOND, D.W. 1996. Vascular dementia: a construct in evolution. Cerebrovas. Brain Metab. Rev. 8: 296-325.
6. 6. LOEB, C. et al. 1996. Vascular dementia: still a debatable entity? J. Neurol. Sci. 143: 31-40.
7. 7. AKIYAMA, H. et al. 1997. Normal human aging: factors contributing to cerebral atrophy. J. Neurol. Sci. 152: 39-49.
8. 8. SKOOG, I. et al. 1996. 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141-1145.
9. 9. KONNO, S. et al. 1997. Classification, diagnosis and treatment of vascular dementia. Drugs & Aging 5: 361-373.
10. 10. MEYER, J.S. et al. 1995. Effects of chronic cigarette smoking and abstention on cerebral perfusion among neurologically normal volunteers. In Brain Imaging of Nicotine and Tobacco Smoking. E. F. Domino, Ed. NPP Books. Michigan.
11. 11. LANCET CONFERENCE WRITING COMMITEE. 1996. The challenge of the dementias. Lancet 347: 1303-1307.
12. 12. FOLSTEIN, M.F. et al. 1975. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 12: 189-198.
13. 13. HERSHEY, L.A. et al. 1987. Validation of cognitive and functional assessment instruments in vascular dementia. Int. J. Psychiatry Med. 17: 183-192.
14. 14. MEYER, J.S. et al. 1995. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke 26: 735-742.
15. 15. MEYER, J.S. et al. 1995. Computed tomography cerebral blood flow values compared in normal aging, ischemic vascular dementia and Alzheimer's disease. In Quantitative Cerebral Blood Flow Measurements Using Stable Xenon/CT: Clinical Applications. M. Tomonaga, A. Tanaka & H. Yonas, Eds. Futura Publishing Co., Inc. New York.
16. 16. MEYER, J.S. et al. 1988. Imaging local cerebral blood flow by xenon-enhanced computed tomography - technical optimization procedures. Neuroradiology 30: 283-292.
17. 17. GOLD, G. et al. 1997. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 49: 690-694.
18. 18. TERAYAMA, Y. et al. 1993. Comparison of polio-araiosis and leuko-araiosis in dementias of ischemic vascular and Alzheimer types. J. Stroke Cerebrovasc. Dis. 3: 267-275.
19. 19. KETY, S.S. 1956. Human cerebral blood flow and oxygen consumption as related to aging. J. Chron. Dis. 3: 478-486.
20. 20. SHEAR, P.K. et al. 1995. Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. Arch. Neurol. 52: 392-402.
21. 21. WALDEMAR, G. 1995. Functional brain imaging with SPECT in normal aging and dementia. Cereb. Brain Metab. Rev. 7: 89-130.
22. 22. MASLIAH, E. et al. 1993. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43: 192-197.
23. 23. VAN ZAGTEN, M. et al. 1996. Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Arch. Neurol. 53: 650-655.
24. 24. BREDESEN, D.E. 1995. Neural apoptosis. Ann. Neurol. 38: 839-851.
25. 25. CHARRIAUT-MARLANGUE, C. et al. 1996. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J. Cereb. Blood Flow Metab. 16: 186-194.
26. 26. STRASSBURGER, T.L. et al. 1997. Interactive effects of age and hypertension on volumes of brain structures. Stroke 28: 1410-1417.
27. 27. TAKEDA, S. et al. 1986. Association of atherosclerosis with increased atrophy of brain matter in the elderly. J. Am. Geriatr. Soc. 34: 259-262.
28. 28. ANDERSON, J.M. et al. 1983. The effect of advanced old age on the neurone content of the cerebral cortex. Observations with an automatic image analyzer point counting method. J. Neurol. Sci. 58: 235-246.
29. 29. PETERS, A. et al. 1996. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J. Neuropathol. Exp. Neurol. 55: 861-874.
30. 30. GEORGE, A.E. et al. 1986. Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies. Am. J. Neuroradiol. 7: 561-566.
31. 31. AWAD, I.A. et al. 1986. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 17: 1084-1089.
32. 32. HACHINSKI, V.C. et al. 1987. Leuko-araiosis. Arch. Neurol. 44: 21-23.
33. 33. STEINGART, A. et al. 1987. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch. Neurol. 44: 36-39.
34. 34. SULLIVAN, P. et al. 1990. Risk factors for white matter changes detected by magnetic resonance imaging in elderly. Stroke 21: 1424-1428.
35. 35. RAIHA, I. et al. 1993. Relationship between vascular factors and white matter low attenuation of the brain. Acta. Neurol. Scand. 87: 286-289.
36. 36. DE LEON, M.J. et al. 1989. Alzheimer's disease: longitudinal CT studies of ventricular change. Am. J. Neuroradiol. 10: 371-376.
37. 37. HEBERT, P.R. et al. 1997. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. J.A.M.A. 278: 313-321.
38. 38. SKOOG, I. 1994. Risk factors for vascular dementia: a review. Dementia 5: 137-144.
39. 39. BRENNER, D.E. et al. 1993. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43: 293-300.
40. 40. KOKMEN, E. et al. 1991. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 41: 1393-1397.
41. 41. LANDIN, K. et al. 1993. Low blood pressure and blood glucose levels in Alzheimer's disease: evidence for a hypometabolic disorder? J. Intern. Med. 233: 357-362.